Search for: "Janssen v. Janssen" Results 21 - 40 of 385
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
27 Nov 2022, 8:41 pm by Patent Docs
Noonan -- On November 15th, the Federal Circuit handed down its opinion affirming all aspects of the District Court's decision in Pharmacyclics LLC v. [read post]
15 Apr 2022, 9:30 pm by ernst
The amicus brief of Serena Mayeri, Melissa Murray, and Reva Siegel in Dobbs v. [read post]
30 Jan 2022, 4:46 pm by INFORRM
On 28 January 2022 Warby LJ refused permission to appeal in Wright v McCormack. [read post]
9 Jan 2022, 1:45 am by Rose Hughes
In Abbvie v Janssen, for example, a claim directed to a functionally defined anti-Il-12 antibody was found invalid for lack of written description despite disclosure in the specification of 300 example antibodies. [read post]
6 Dec 2021, 6:24 am by Lisa Larrimore Ouellette
Phase 2/3 clinical trials began in February 2021 for Pfizer/BioNTech and Janssen and included pregnant people. [read post]
22 Nov 2021, 4:03 am by Matthew L.M. Fletcher
, this case is definitive proof that the Lewis v. [read post]
27 Oct 2021, 5:15 am by Dennis Crouch
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
22 Oct 2021, 11:36 am by Pamela Wolf
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
22 Oct 2021, 11:36 am by Pamela Wolf
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
20 Sep 2021, 3:31 pm by Dennis Crouch
Janssen Pharmaceutica (appealing institution denials); Apple Inc. v. [read post]